These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15490771)

  • 1. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
    Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW
    Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J; Lánská V; Hulínský V
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients.
    Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M
    Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension.
    Fairhurst GJ
    Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Alonso I; Fernández JR
    Chronobiol Int; 2010 May; 27(3):560-74. PubMed ID: 20524801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
    Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement.
    Fitscha P; Meisner W
    Blood Press Suppl; 1994; 1():36-9. PubMed ID: 8205296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J; Fiser B; Dusek J
    Vnitr Lek; 1996 Feb; 42(2):98-101. PubMed ID: 8686198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.